SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is trending due to a preliminary update from its Phase III FLAMINGO-01 trial showing that GP2 treatment reduced breast cancer recurrence rates to less than 1% in the open-label arm, significantly outperforming historical benchmarks. Investors are closely monitoring upcoming AACR conference abstract releases and poster presentations, with community discussion focused on this data as a potential catalyst for institutional interest, partnerships, or a future buyout.

MNDE is the governance token for Marinade. Marinade helps you to stake Solana without locking in liquidity by turning SOL into mSOL - tokenized version of staked SOL. This way you can both secure the network by staking SOL, and use your mSOL as the ultimate unit in Solana DeFi ecosystem. To provide liquidity, deposit in lending protocols and even buy NFTs.

Marinade

Marinade is seeing increased chatter as investors speculate on a breakout, with many in the community highlighting its significant total value locked relative to its market cap. Traders are actively tracking bullish technical patterns and potential institutional integration, viewing it as an undervalued play within the Solana ecosystem.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is experiencing significant market interest driven by anticipation for upcoming Phase 3 readouts of its lead psychedelic-derived assets and recent bullish analyst initiations. Community discussion is heavily focused on the company's rebranding, skepticism regarding management's history of corporate restructuring, and debates over the scalability of its mental health pipeline compared to sector peers.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is experiencing significant volatility following a corporate rebranding and Nasdaq listing, with the community sharply divided between those optimistic about its upcoming Phase 2 generalized anxiety disorder data and Phase 3 major depressive disorder milestones and skeptics pointing to a history of dilution and management concerns. Investors are closely monitoring the company's capital runway and leadership changes while debating whether the stock's current valuation represents a distressed entry point for a potential acquisition or a continued downward trend.

Highstreet

Highstreet ($HIGH) is actively being monitored by traders as a high-volatility play, with the community analyzing whale accumulation patterns and comparing it to previous rapid surges. Despite concerns over volatility and price corrections, discussions remain polarized between those anticipating a major short squeeze and others expressing frustration with price action.

AEVEX Corp. operates as a holding company. It operates through Tactical Systems and Global Solutions segments. The Tactical Systems segment focuses on design, development, and production of autonomous systems including unmanned aerial systems and unmanned surface vessels. The Global Solutions segment offers services and mission support to defense and intelligence customers. The company was founded in 2017 and is headquartered in Solana Beach, CA.

AEVEX Corp. - Ordinary Shares - Class A

AEVEX Corp. is trending following a strong NYSE market debut that captured investor interest in its specialized drone and automated defense technology. Community discussion is focused on the stock's momentum as a defense sector play with significant government contract backing, drawing comparisons to other high-volatility IPOs.

Advisorshares Trust - AdvisorShares Psychedelics ETF

AdvisorShares Psychedelics ETF

Investors are actively debating the potential for long-term growth in the psychedelics sector, with many viewing current price levels as a deep-value opportunity despite ongoing volatility and concerns regarding fund management. The conversation is driven by optimism surrounding emerging clinical trial data, potential regulatory shifts, and the long-term role of these companies in the evolving mental health landscape.

VanEck ETF Trust - VanEck Digital Transformation ETF

VanEck Digital Transformation ETF

VanEck Digital Transformation ETF is generating interest as investors note a bullish shift in internal market breadth and a rotation into high-beta tech and blockchain components. The community is closely watching this sector pivot as an potential indicator of broader risk appetite recovery, with traders actively debating the fund's momentum against broader market indices.

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Teva- Pharmaceutical Industries Ltd. - ADR

Teva is currently surging as investors react to a strong quarterly earnings report, which was bolstered by double-digit growth in its branded drug portfolio and an increased sales outlook for its flagship product, Austedo. The community is actively discussing the company's successful "Pivot to Growth" strategy, its focus on debt reduction, and the potential for a technical breakout as institutional interest intensifies.

Bonk is a dog-themed memecoin on the Solana blockchain, launched on Christmas Day 2022 to revitalize the Solana community following the FTX collapse. Created by an anonymous team of 22 Solana developers and builders, Bonk distributed 50% of its total 100 trillion token supply via airdrop to community members including NFT collectors, developers, and artists.   The project positions itself as "the first Solana dog coin for the people, by the people," explicitly rejecting venture capital backing in favor of grassroots community ownership. What sets Bonk apart from other memecoins is its combination of fair launch mechanics, extensive ecosystem integration, and active deflationary strategy.   Built on Solana, BONK benefits from fast transaction speeds and low fees that make it practical for everyday use. Native products include LetsBonk.fun (a memecoin launchpad that briefly became Solana's market leader in 2025, surpassing Pump.fun with over 78% market share), BonkSwap (a decentralized exchange) and BonkBot (a Telegram trading bot with built-in burn mechanics).   BONK is available across 10 blockchain networks and listed on major exchanges including Binance, Coinbase, Kraken, and Robinhood. Governance is handled by BonkDAO, which holds 15% of the token supply and makes decisions through on-chain voting.   The community has organized several major burn events, most notably the December 2024 BURNmas campaign that destroyed 1.69 trillion tokens worth over $50 million. In September 2025, Nasdaq-listed Safety Shot, Inc. formed BONK Holdings LLC and acquired over 2.5% of the circulating supply (valued at $55-63 million), making BONK one of the first memecoins to attract formal corporate treasury adoption. Core contributor Nom was appointed to Safety Shot's board, and the company holds a 10% revenue share in LetsBonk.fun.  As with all memecoins, BONK is a highly speculative asset with substantial volatility. Its value is primarily driven by community sentiment, social media momentum, and meme culture rather than traditional utility.   The anonymous team, while common in the memecoin space, means investors should exercise appropriate caution. Despite these risks, Bonk has established itself as one of the most successful community-driven tokens in the Solana ecosystem, approaching 1 million unique holders and expanding from a simple memecoin into meaningful DeFi infrastructure.

BONK

BONK is trending as the community actively debates its potential for a massive breakout, with many holders citing an upcoming token burn and a surge in wallet addresses as key catalysts. Discussions are split between high-conviction bulls accumulating the dip and skeptics dismissing it as a volatile meme asset, all while traders closely monitor its correlation with broader market movements.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cameco Surges 200% in a Year: Buy, Sell or Hold the Stock?

CCJ rides nuclear tailwinds with strong earnings growth and long-term contracts, but a rich valuation and softer 2026 outlook raise entry timing questions.

Uranium Energy Corp Commences Production at Burke Hollow, the World's Newest Operating ISR Uranium Mine

Uranium Energy Corp Commences Production at Burke Hollow, the World's Newest Operating ISR Uranium Mine Uranium Energy Corp Commences Production at Burke Hollow, the World's Newest Operating ISR...

UUUU Surges 418% in a Year: Buy, Sell or Hold the Stock?

Energy Fuels' 418% surge rides rare earth breakthroughs and uranium growth, but stretched valuation and near-term losses may give investors pause.

27,000 Feet of Drilling, 47 Diamond Holes, and one of the Largest Uranium Deposits in America:

27,000 Feet of Drilling, 47 Diamond Holes, and one of the Largest Uranium Deposits in America: 27,000 Feet of Drilling, 47 Diamond Holes, and one of the Largest Uranium Deposits in America: PR...

Can Denison Mines' Phoenix Project Power Its Next Growth Phase?

DNN advances Phoenix ISR uranium mine after approvals, targeting 2028 production and aiming to deliver low-cost supply as global uranium markets tighten.

Cameco vs. Uranium Energy: Which Uranium Stock is the Better Buy?

CCJ stands out against UEC with stronger earnings visibility, contracts and valuation, positioning the former as the more compelling uranium play.

Uranium Energy Corp Receives Approval for Expanded Production at Christensen Ranch and Secures NRC Docketing for U.S. Conversion Facility

Uranium Energy Corp Receives Approval for Expanded Production at Christensen Ranch and Secures NRC Docketing for U.S. Conversion Facility Uranium Energy Corp Receives Approval for Expanded Production...

Significant U.S. Uranium Deposit Advances with Permitting Team NUCL, CCJ, UEC, SMR, and NXE as Uranium Demand Meets Domestic Supply Urgency

Significant U.S. Uranium Deposit Advances with Permitting Team NUCL, CCJ, UEC, SMR, and NXE as Uranium Demand Meets Domestic Supply Urgency Significant U.S. Uranium Deposit Advances with Permitting...

Wall Street Analysts Think Uranium Energy (UEC) Is a Good Investment: Is It?

According to the average brokerage recommendation (ABR), one should invest in Uranium Energy (UEC). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Uranium Energy Corp Reports Results for Second Quarter of Fiscal 2026

Uranium Energy Corp Reports Results for Second Quarter of Fiscal 2026 Uranium Energy Corp Reports Results for Second Quarter of Fiscal 2026 PR Newswire CORPUS CHRISTI, Texas, March 10, 2026...

Uranium Energy Corp. engages in the provision of uranium and titanium mining and related activities, including exploration, pre-extraction, extraction, and processing of uranium concentrates, and titanium minerals. It operates through the following geographical segments: Wyoming, Texas, Saskatchewan, and Others. The company was founded by Alan P. Lindsay and Amir Adnani on May 16, 2003 and is headquartered in Corpus Christi, TX.

UEC
Uranium Energy Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest UEC News

UECUranium Energy Corp